ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.60
-0.34%
US Tech 100
17,650.00
0.05%
S&P 500
5,222.68
0.16%
US Dollar vs CAD
1.36775
-0.01%
Bitcoin
60,883.22
0.14%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Panacea Acquisition Corp (NUVB)

  7. Panacea Acquisition Corp (NUVB) News

NUVB

Panacea Acquisition (NUVB)

Panacea Acquisition Corp
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:NUVB
DateTimeSourceHeadlineSymbolCompany
04/24/20249:01AMBusiness WireNuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNYSE:NUVBPanacea Acquisition Corp
04/10/20243:01PMBusiness WireNuvation Bio Completes Acquisition of AnHeart TherapeuticsNYSE:NUVBPanacea Acquisition Corp
03/28/20247:00AMBusiness WireNuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial OfficerNYSE:NUVBPanacea Acquisition Corp
03/25/20246:00AMBusiness WireNuvation Bio to Acquire AnHeart Therapeutics in All-Stock TransactionNYSE:NUVBPanacea Acquisition Corp
03/14/20243:05PMBusiness WireNuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid TumorsNYSE:NUVBPanacea Acquisition Corp
03/04/20244:30PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:NUVBPanacea Acquisition Corp
03/04/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
03/04/20243:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
03/04/20243:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
02/29/20244:06PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:NUVBPanacea Acquisition Corp
02/29/20243:48PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
02/29/20243:01PMBusiness WireNuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
01/10/20243:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
01/10/20243:21PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
01/08/20243:58PMDow Jones NewsNuvation Bio Gets New Drug Application Clearance From FDA for Solid Tumor TreatmentNYSE:NUVBPanacea Acquisition Corp
01/08/20243:17PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
01/08/20243:10PMBusiness WireNuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of DirectorsNYSE:NUVBPanacea Acquisition Corp
01/08/20243:05PMBusiness WireNuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid TumorsNYSE:NUVBPanacea Acquisition Corp
12/14/20233:02PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
11/27/20233:09PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NUVBPanacea Acquisition Corp
11/27/20233:01PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
11/13/20233:11PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
11/13/20233:05PMBusiness WireNuvation Bio Announces Departure of Chief Financial OfficerNYSE:NUVBPanacea Acquisition Corp
11/02/20233:23PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
11/02/20233:21PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NUVBPanacea Acquisition Corp
11/02/20233:10PMBusiness WireNuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
08/03/20234:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:NUVBPanacea Acquisition Corp
08/03/20233:17PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NUVBPanacea Acquisition Corp
08/03/20233:10PMBusiness WireNuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business UpdateNYSE:NUVBPanacea Acquisition Corp
06/01/20233:05PMBusiness WireNuvation Bio Announces Formation of Oncology-Focused Scientific Advisory BoardNYSE:NUVBPanacea Acquisition Corp
 Showing the most relevant articles for your search:NYSE:NUVB

Your Recent History

NASDAQ
RNAZ
TransCode Therapeutics
USOTC
SRMX
Saddle Ranch Media (PK)
USOTC
FMCC
Federal Home Loan Mortgage (QB)
USOTC
FNMA
Fannie Mae (QB)
USOTC
PHIL
PHI (PK)
NASDAQ
COOP
Mr Cooper
USOTC
ECSL
Ecare Solutions (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
AXXA
Exxe (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
RONN
Ronn Motor (PK)
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
TPTW
TPT Global Tech (CE)
NASDAQ
SEV
Sono Group NV
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved